{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T03:01:21Z","timestamp":1769914881432,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T00:00:00Z","timestamp":1524182400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Polish National Science Centre","doi-asserted-by":"crossref","award":["UMO-2016\/21\/B\/NZ6\/02279"],"award-info":[{"award-number":["UMO-2016\/21\/B\/NZ6\/02279"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004281","name":"Polish National Science Centre","doi-asserted-by":"crossref","award":["UMO-2012\/05\/B\/NZ6\/00792"],"award-info":[{"award-number":["UMO-2012\/05\/B\/NZ6\/00792"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"crossref","award":["DS460"],"award-info":[{"award-number":["DS460"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3097-6","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T07:24:24Z","timestamp":1524209064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia - case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Jacek","family":"Roli\u0144ski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-4741","authenticated-orcid":false,"given":"Ewelina","family":"Grywalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Pyzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Dzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violetta","family":"Opoka-Winiarska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Surdacka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Maj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franciszek","family":"Burdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Piro\u017cy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Grabarczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Staros\u0142awska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,20]]},"reference":[{"issue":"2","key":"3097_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/blood.V98.2.280","volume":"98","author":"H Kimura","year":"2001","unstructured":"Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001;98(2):280\u20136.","journal-title":"Blood"},{"issue":"4","key":"3097_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1086\/367988","volume":"187","author":"H Kimura","year":"2003","unstructured":"Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, Imai S, Okano M, Morio T, Yokota S, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis. 2003;187(4):527\u201333.","journal-title":"J Infect Dis"},{"issue":"10","key":"3097_CR3","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1086\/587671","volume":"46","author":"K Gotoh","year":"2008","unstructured":"Gotoh K, Ito Y, Shibata-Watanabe Y, Kawada J, Takahashi Y, Yagasaki H, Kojima S, Nishiyama Y, Kimura H. Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. Clin Infect Dis. 2008;46(10):1525\u201334.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"3097_CR4","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","volume":"20","author":"JI Cohen","year":"2009","unstructured":"Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol. 2009;20(9):1472\u201382.","journal-title":"Ann Oncol"},{"issue":"4","key":"3097_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3904\/kjim.2011.26.4.466","volume":"26","author":"EJ Joo","year":"2011","unstructured":"Joo EJ, Ha YE, Jung DS, Cheong HS, Wi YM, Song JH, Peck KR. An adult case of chronic active Epstein-Barr virus infection with interstitial pneumonitis. Korean J Intern Med. 2011;26(4):466\u20139.","journal-title":"Korean J Intern Med"},{"issue":"22","key":"3097_CR6","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","volume":"117","author":"JI Cohen","year":"2011","unstructured":"Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, et al. Characterization and treatment of chronic active Epstein\u00adBarr virus disease: a 28\u00adyear experience in the United States. Blood. 2011;117(22):5835\u201349.","journal-title":"Blood"},{"key":"3097_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/00015550310002675","volume":"83","author":"H Mitsui","year":"2003","unstructured":"Mitsui H, Komine M, Shirai A, Kanda N, Asahina A, Okochi H, Hitomi S, Kimura S, Tamaki K. Chronic active EB virus infection complicated with IgG3 subclass deficiency: an adult case treated with intravenous immunoglobulin and IFN-alpha. Acta Derm Venereol. 2003;83:31\u20135.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"3097_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ajh.20398","volume":"80","author":"M Okano","year":"2005","unstructured":"Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol. 2005;80(1):64\u20139.","journal-title":"Am J Hematol"},{"key":"3097_CR9","doi-asserted-by":"publisher","unstructured":"Owusu Sekyere S, Suneetha PV, Hardtke S, Falk CS, Hengst J, Manns MP, Cornberg M, Wedemeyer H, Schlaphoff V. Type I interferon elevates co-regulatory receptor expression on CMV- and EBV-specific CD8 T cells in chronic hepatitis C. Front Immunol. 2015; \n                    https:\/\/doi.org\/10.3389\/fimmu.2015.00270\n                    \n                  .","DOI":"10.3389\/fimmu.2015.00270"},{"issue":"3","key":"3097_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/1753465816630208","volume":"10","author":"H Iannella","year":"2016","unstructured":"Iannella H, Luna C, Waterer G. Inhaled corticosteroids and the increased risk of pneumonia: what's new? A 2015 updated review. Ther Adv Respir Dis. 2016;10(3):235\u201355.","journal-title":"Ther Adv Respir Dis"},{"issue":"6","key":"3097_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.hrtlng.2016.08.011","volume":"45","author":"BA Cunha","year":"2016","unstructured":"Cunha BA, Gian J. Diagnostic dilemma: Epstein-Barr virus (EBV) infectious mononucleosis with lung involvement or co-infection with Legionnaire's disease? Heart Lung. 2016;45(6):563\u20136.","journal-title":"Heart Lung"},{"issue":"6","key":"3097_CR12","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/crj.12433","volume":"11","author":"H He","year":"2017","unstructured":"He H, Wang Y, Wu M, Sun B. Positive Epstein-Barr virus detection and mortality in respiratory failure patients admitted to the intensive care unit. Clin Respir J. 2017;11(6):895\u2013900.","journal-title":"Clin Respir J"},{"issue":"3","key":"3097_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/ppul.10244","volume":"35","author":"T Ankermann","year":"2003","unstructured":"Ankermann T, Claviez A, Wagner HJ, Krams M, Riedel F. Chronic interstitial lung disease with lung fibrosis in a girl: uncommon sequelae of Epstein-Barr virus infection. Pediatr Pulmonol. 2003;35(3):234\u20138.","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"3097_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1034\/j.1399-3003.2000.15d28.x","volume":"15","author":"A Pfleger","year":"2000","unstructured":"Pfleger A, Eber E, Popper H, Zach MS. Chronic interstitial lung disease due to Epstein-Barr virus infection in two infants. Eur Respir J. 2000;15(4):803\u20136.","journal-title":"Eur Respir J"},{"issue":"6","key":"3097_CR15","first-page":"603","volume":"8","author":"ME Trigg","year":"1989","unstructured":"Trigg ME, de Alarcon P, Rumelhart S, Holida M, Giller R. Alpha-interferon therapy for lymphoproliferative disorders developing in two children following bone marrow transplants. J Biol Response Mod. 1989;8(6):603\u201313.","journal-title":"J Biol Response Mod"},{"issue":"4","key":"3097_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/00043426-199807000-00013","volume":"20","author":"Y Sakai","year":"1998","unstructured":"Sakai Y, Ohga S, Tonegawa Y, et al. Interferon-a therapy for CAEBV chronic active Epstein-Barr virus infection: potential effect on the development of T-lymphoproliferative disease. J Pediatr Hematol Oncol. 1998;20(4):342\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"3097_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/bmt.2010.122","volume":"46","author":"K Kawa","year":"2011","unstructured":"Kawa K, Sawada A, Sato M, Okamura T, Sakata N, Kondo O, Kimoto T, Yamada K, Tokimasa S, Yasui M, et al. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transplant. 2011;46(1):77\u201383.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"3097_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/ejh.12151","volume":"91","author":"Y Watanabe","year":"2013","unstructured":"Watanabe Y, Sasahara Y, Satoh M, Looi CY, Katayama S, Suzuki T, Suzuki N, Ouchi M, Horino S, Moriya K, et al. A case series of CAEBV of children and young adults treated with reduced-intensity conditioning and allogeneic bone marrow transplantation: a single-center study. Eur J Haematol. 2013;91(3):242\u20138.","journal-title":"Eur J Haematol"},{"issue":"8844","key":"3097_CR19","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/0140-6736(93)90323-9","volume":"341","author":"Y Ishida","year":"1993","unstructured":"Ishida Y, Yokota Y, Tauchi H, Fukuda M, Takaoka T, Hayashi M, Matsuda H. Ganciclovir for chronic active Epstein-Barr virus infection. Lancet. 1993;341(8844):560\u20131.","journal-title":"Lancet"},{"issue":"4","key":"3097_CR20","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12185-017-2192-6","volume":"105","author":"A Sawada","year":"2017","unstructured":"Sawada A, Inoue M, Kawa K. How we treat chronic active Epstein-Barr virus infection. Int J Hematol. 2017;105(4):406\u201318.","journal-title":"Int J Hematol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3097-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3097-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3097-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T19:08:35Z","timestamp":1555700915000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3097-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,20]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3097"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3097-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,20]]},"assertion":[{"value":"16 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Medical University of Lublin (Decision No. KE-0254\/227\/2010).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"190"}}